Both HIF-1 (activated by hypoxia and reoxygenation after radiotherapy) and stromal cell-derived factor-1 (SDF-1), along with its receptor CXCR4, play a crucial role in recruiting bone marrow-derived cells (BMDCs) to the tumor [227,228,229,230]. Here, HIF1A is linked to neoplasm.